Global burden of hematologic malignancies and evolution patterns over the past 30 years

1

The global burden of hematologic malignancies is increasing due to an aging population and changing epidemiological patterns.
2

Hematologic malignancies include leukemia, multiple myeloma, non-Hodgkin lymphoma, and Hodgkin lymphoma, with varying incidence across regions.
3

Survival rates for hematologic malignancies have improved, but understanding morbidity and mortality trends remains crucial for prevention strategies.
4

The Global Burden of Disease project provides valuable epidemiological data on hematologic malignancies, aiding healthcare decision-making.
5

Data from 204 countries on hematologic malignancies were analyzed, revealing significant insights into incidence, mortality, and socio-demographic influences.

Blood Cancer Journal

by Nan Zhang, Jinxian Wu, Qian Wang, Yuxing Liang, Xinqi Li, Guopeng Chen, Linlu Ma, Xiaoyan Liu, Fuling Zhou
May 17, 2023

1